Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Non-Protected Left Main Coronary Artery Disease: 1-Year Outcomes in a High Volume Single Center Study.
Ștefan Dan Cezar MoțAdela Mihaela ȘerbanRuxandra Ștefana BeyerMihai CocoiHoria IugaIoana Dănuța MureșanSimona CozmaAlexandra Dădârlat-PopRaluca TomoaiaDana PopPublished in: Life (Basel, Switzerland) (2022)
In patients with LMCS, PCI with drug-eluting stents was non-inferior to CABG with respect to the composite of cardiac death, myocardial infarction, repeat revascularization and stroke at 1 year, even in patients with intermediate Syntax II risk score.
Keyphrases
- coronary artery bypass grafting
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- atrial fibrillation
- left ventricular
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- cardiovascular events
- heart failure
- coronary artery bypass
- adverse drug
- metabolic syndrome
- aortic stenosis
- brain injury
- drug induced
- glycemic control
- insulin resistance